Indiana’s chief judge to serve on opioid panel
The panel will help promote collaboration among treatment providers, criminal justice systems and child welfare agencies.
Health Care & Insurance
Articles
Hospital system leases north-side building
St. Vincent Health filed an application Sept. 22 with the state, seeking to remodel 192,327 square feet of the Parkwood West Building, 250 West 96th St., for administrative offices.
Employers, workers brace for another round of health premium increases
The National Business Group on Health is projecting the total cost of providing medical and pharmacy benefits to increase 5 percent for the fifth consecutive year in 2018.
LifeOmic teams with IU, Regenstrief on precision medicine
The startup, founded by serial entrepreneur Don Brown, has hashed out a deal that it gives it access to a broad range of intellectual property.
GOP concedes on last-gasp attempt to repeal Obamacare
Senate Republicans, short of votes, abandoned their latest and possibly final attempt to kill the health care law Tuesday, just ahead of a critical end-of-the-week deadline.
Ex-American Senior Communities CFO who avoided indictment blasted in new lawsuit
Roger Werner played a “central role” in helping fellow executives fleece the nursing home company, according to a new federal lawsuit.
Indiana health leaders brace for possible Obamacare repeal
Health experts at an IBJ Health Care & Benefits panel discussion on Thursday said passage of the Graham-Cassidy bill could challenge Indiana's ability to care for low-income Hoosiers.
Holcomb signs letter backing Senate GOP’s health care bill
Indiana Gov. Eric Holcomb has joined 14 other Republican governors in backing a last-ditch GOP effort to repeal former President Barack Obama's signature health care law.
Anthem buys Florida insurer in first acquisition since Cigna deal failed
The deal for HealthSun gives Anthem another 40,000 members and helps build its base in south Florida.
Walgreens, Rite Aid revise store purchase deal to $4.38B
Walgreens and Rite Aid have finally devised a combination of the nation's largest and third-largest drugstore chains that will get past antitrust regulators.
Cook Group selling drug unit for $950M, buying former GE factory
Cook officials cast the sale of Cook Pharmica and the purchase of what once was the world’s largest refrigerator factory as good news for Bloomington.
Longtime OB-GYN named new Indiana state health commissioner
Dr. Kristina Box will take over Indiana’s top health job next month, succeeding Dr. Jerome Adams, who resigned to become U.S. surgeon general.
Indiana sees decrease in residents without health insurance
About 8 percent, or 530,000, Indiana residents lacked medical insurance in 2016, compared to 14 percent, or 903,000, residents in 2013.
Anthem expands Obamacare options in Virginia to fill holes
Anthem Inc. reversed course and said it will offer Obamacare plans in Virginia, after a pullback by another insurer threatened to leave the state with large gaps in coverage.
$70,000 settlement reached in Anderson housing lawsuit
The agreement calls for the housing authority in the central Indiana community to compensate seven victims of discrimination identified by the U.S. Department of Justice.
Analysts see Trump threats to insurers boosting premiums
Average premiums for individually purchased health insurance will grow around 15 percent next year, the Congressional Budget Office projected.
Animal-health biz Elanco under the weather; Lilly won’t rule out spinoff
The Greenfield-based unit, which makes a vast array of vaccines, antibiotics, feed additives and other health products for livestock and pets, is in a slump, after more than a decade of growth.
Anthem weighs retreating from even more Obamacare markets
The Indianapolis-based health insurer is in talks with officials in some states ahead of deadlines later this month to decide whether to sell coverage in 2018, CEO Joseph Swedish said Tuesday.
Insurance stocks jump as Irma avoids worst-case scenario
Hurricane Irma weakened as it moved past Tampa on Monday, leaving in its wake a state that avoided the worst predictions of its destruction by sea and storm.
Lilly breast cancer drug results could challenge Pfizer pill
li Lilly and Co.’s experimental breast cancer drug abemaciclib, when combined with standard therapy, slowed the progression of tumors in patients with an advanced form of the disease.